« Back
Home /
RKI-1447

RKI-1447

Item no.	V1346-250mg
Manufacturer	InvivoChem LLC
CASRN	1342278-01-6
Amount	250 mg
Quantity options	100 mg 10 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Description	InvivoChem Cat #:V1346CAS #:1342278-01-6Purity >=98% Description: RKI-1447 (ROCK Inhibitor XIII; RKI 1447; RKI1447) is a potent small molecule inhibitor of ROCK1 and ROCK2 with potential antitumor activities against breast cancer. It inhibits ROCK1 and ROCK2 with IC50s of 14.5 nM and 6.2 nM, respectively. RKI-1447 is a Type I kinase inhibitor that binds the ATP binding site through interactions with the hinge region and the DFG motif. RKI-1447 suppressed phosphorylation of the ROCK substrates MLC-2 and MYPT-1 in human cancer cells. References: Cancer Res. 2012 Oct 1; 72(19):5025-34; Medchemcomm. 2012 Jun 1; 3(6):699-709.
Molecular Weight (MW)	326.37
Formula	C16H14N4O2S
CAS No.	1342278-01-6
Storage	-20C for 3 years in powder form
	-80C for 2 years in solvent
Solubility (In vitro)	DMSO: 65 mg/mL (199.16 mM)
	Water:< 1 mg/mL
	Ethanol:< 1 mg/mL
Solubility (In vivo)	15% Captisol: 15 mg/mL
Synonyms	RKI 1447; ROCK Inhibitor XIII; RKI-1447; RKI1447;

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 9/4/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer